AGI-H-15

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAGI-H-15
Drug Alias NameAGI-H-15
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsAtherosclerosisCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAtherogenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAtherogenics Inc
Active IndicationsN/A
Inactive IndicationsAtherosclerosisCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A